The IGF system in patients with type 2 diabetes: associations with markers of cardiovascular target organ damage

Insulin-Like Growth Factor 1 and Insulin-Like Growth Factor–Binding Protein 3 in Relation to the Risk of Type 2 Diabetes Mellitus: Results From the EPIC–Potsdam Study

(2016) Dagmar Drogan et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Discrepancies in insulin-like growth factor signaling? No, not really

(2016) Cheryl A. Conover   GROWTH HORMONE & IGF RESEARCH

Repurposing metformin: an old drug with new tricks in its binding pockets

(2015) R. Pryor et al.   BIOCHEMICAL JOURNAL

PAPP-A and IGFBP-4 fragment levels in patients with ST-elevation myocardial infarction treated with heparin and PCI

(2015) Rikke Hjortebjerg et al.   CLINICAL BIOCHEMISTRY

IGFBP-4 Fragments as Markers of Cardiovascular Mortality in Type 1 Diabetes Patients With and Without Nephropathy

(2015) Rikke Hjortebjerg et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Morning blood pressure surge and target organ damage in newly diagnosed type 2 diabetic patients: a cross sectional study

(2015) Johanne M. Lyhne et al.   BMC Endocrine Disorders

Cross-sectional and longitudinal relation of IGF1 and IGF-binding protein 3 with lipid metabolism

(2014) Marie-Luise Eggert et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

GLP-1 infusion reduces IGFBP-1 serum level in humans

(2014) Jeppe Skov et al.   GROWTH HORMONE & IGF RESEARCH

Reference Intervals for Insulin-like Growth Factor-1 (IGF-I) From Birth to Senescence: Results From a Multicenter Study Using a New Automated Chemiluminescence IGF-I Immunoassay Conforming to Recent International Recommendations

(2014) Martin Bidlingmaier et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Age- and Sex-Specific Reference Intervals Across Life Span for Insulin-Like Growth Factor Binding Protein 3 (IGFBP-3) and the IGF-I to IGFBP-3 Ratio Measured by New Automated Chemiluminescence Assays

(2014) Nele Friedrich et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The Association Between IGF-I/IGFBP-3 and Subclinical End Points: Epidemiology Faces the Limits

(2014) Christiane Müller et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

IGF-I and IGFBP2 in peripheral artery disease: results of a prospective study

(2014) Grazina Urbonaviciene et al.   SCANDINAVIAN CARDIOVASCULAR JOURNAL

Determination of IGFs and their binding proteins

(2013) Rikke Hjortebjerg et al.   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

Clinical differences between total PAPP-A and measurements specific for the products of free PAPP-A activity in patients with stable cardiovascular disease

(2013) Olaf Schulz et al.   CLINICAL BIOCHEMISTRY

Insulin growth factor binding proteins as therapeutic targets in type 2 diabetes

(2013) Rikke Hjortebjerg et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Effect of hyperinsulinemia during hemodialysis on the insulin-like growth factor system and inflammatory biomarkers: a randomized open-label crossover study

(2013) Mark Reinhard et al.   BMC Nephrology

Metformin Down-regulates TNF-α Secretion via Suppression of Scavenger Receptors in Macrophages

(2013) Bobae Hyun et al.   Immune Network

N-terminal and C-terminal fragments of IGFBP-4 as novel biomarkers for short-term risk assessment of major adverse cardiac events in patients presenting with ischemia

(2012) A.B. Postnikov et al.   CLINICAL BIOCHEMISTRY

Insulin-Like Growth Factor Axis and Risk of Type 2 Diabetes in Women

(2012) S. N. Rajpathak et al.   DIABETES

Carotid-Femoral Pulse Wave Velocity Is Associated With Cerebral White Matter Lesions in Type 2 Diabetes

(2012) E. Laugesen et al.   DIABETES CARE

Metabolic Actions of Insulin-Like Growth Factor-I in Normal Physiology and Diabetes

(2012) David R. Clemmons   ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA

Effects of bench step exercise on arterial stiffness in post-menopausal women: Contribution of IGF-1 bioactivity and nitric oxide production

(2012) Masanori Ohta et al.   GROWTH HORMONE & IGF RESEARCH

Key questions and answers about pregnancy-associated plasma protein-A

(2012) Cheryl A. Conover   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Calcineurin inhibitors acutely improve insulin sensitivity without affecting insulin secretion in healthy human volunteers

(2011) Lara Aygen Øzbay et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Associations of IGF1 and IGFBPs 1 and 3 with all-cause and cardiovascular mortality in older men: the Health In Men Study

(2011) Bu B Yeap et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Normalized Wall Index Specific and MRI-Based Stress Analysis of Atherosclerotic Carotid Plaques

(2010) Chengcheng Zhu et al.   CIRCULATION JOURNAL

Vascular Aging

(2009) Peter M. Nilsson et al.   HYPERTENSION

IGF-dependent and IGF-independent actions of IGF-binding protein-1 and -2: implications for metabolic homeostasis

(2009) Stephen B. Wheatcroft et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

IGF-I/IGFBP-3 ratio: a mechanistic insight into the metabolic syndrome

(2008) Justo Sierra-Johnson et al.   CLINICAL SCIENCE

Insulin-like growth factor-binding protein-1 in the prediction and development of type 2 diabetes in middle-aged Swedish men

(2008) M. S. Lewitt et al.   DIABETOLOGIA

The role of IGF-I and its binding proteins in the development of type 2 diabetes and cardiovascular disease

(2007) Vivienne A. Ezzat et al.   DIABETES OBESITY & METABOLISM